67 Annex 2
BOX 2: ACTIVITIES RELATED TO CEWG RECOMMENDATIONS CONDUCTED AT THE REGIONAL LEVEL
ACTIVITY IMPORTANT RECOMMENDATIONOUTCOME
1. Conduct of Regional Consultation for
Development of a Regional Framework on Public Health,
Innovation and Intellectual Property in New Delhi on 5-6 April, 2011
13
SEAR Member States identified national and regional priorities for the 8 elements and 25 sub-elements of
the GSPA, and presented a set of recommendations for WHO and Member States of the region that
requires further engagement at national, regional and global levels
2.1 Conduct of Regional Technical
Consultation in Bangkok, Thailand on 15- 17 August 2012
14
2.2 Regional technical discussion of the
CEWG Report conducted during the 65
th
SEA Regional Committee Meeting in Yogyakarta, Indonesia on 7 Sept. 2012
2.3
Regional Resolution SEARC65R3 Consultative Expert Working Group
on Research and Development: Financing and Coordination adopted
during 65
th
SEA Regional Committee Meeting
12
“To engage actively in the negotiations in an open- ended meeting of Member States in November 2012,
inter alia, by supporting the development of the Global Health RD Observatory, effective global RD
coordination, adequate and sustainable funding for RD on diseases of Type II and III and specific RD
needs of diseases of Type I in developing coun
tries”
0.14
3.1 Conduct of country studies in Thailand, India, Bangladesh, Sri Lanka and
Indonesia to document existing norms and standards followed in the
classification of health RD activities; to identify current and future priorities for
RD for health products and to identify project which need to be implemented in
order to develop and deliver priority health products
3.2 Conduct of Regional Consultation for
Developing a Strategic Workplan as a follow-up of the Report of the
Consultative Expert Working group CEWG on Research and
Development: Financing and Coordination held in Bangkok, Thailand
on 25-26 July 2013
15
The participants of the Regional Consultation presented 6 recommendations for the development of
norms and standards for the classification of health RD towards setting-up of RD observatories. These
include, among others, the following:
15
a. Setting-up of a national RD observatory to
collect, analyse, coordinate, prioritize and monitor RD resource flows from the public and
private sectors; b.
Member States may develop modalities and identify institutional entities to develop,
establish, maintain and manage health RD observatories;
c. Member States may pilot-test the proposed
classification grid for norms and standards for RD in terms of diseases, product development
and policy. In the same meeting, 7 potential priority areas for
RD demonstration projects were identified and ranked.
68
BOX 2: ACTIVITIES RELATED TO CEWG RECOMMENDATIONS CONDUCTED AT THE REGIONAL LEVEL
ACTIVITY IMPORTANT RECOMMENDATIONOUTCOME
4. Meeting of Experts on Demonstration Projects held in New Delhi, India on 24-
25 October 2013
16
Identified 4 research and development demonstration projects for submission to and consideration at the
Technical Consultative Meeting to be held in Geneva on 3-5 December 2013. These were:
16
1. Combatting tuberculosis in the region
development of diagnostics and drugs 2.
Project on medicines and devices for diabetes mellitus
3. Multiplexed point-of-care test for acute febrile
illness 4.
Dengue vaccine development
5. Regional Meeting for the Assessment of Progress in Implementing Global
Strategy and Plan of Action on Public Health, Innovation and Intellectual
Property for Southeast Asia held in Bangkok, Thailand on 16-18 December,
2014 Member States agreed to provide a self-assessment
as established by WHA62.16 and develop a priority mapping for the GSPA next steps, using the matrix
agreed upon during the Consultation. WHO is asked to summarize and consolidate the results of the GSPA
self-assessment and forward it from SEARO to WHA. Specific actions by Member States and WHO in
relation to each of the 8 GSPA elements were also identified.
69 Annex 2 Contd
BOX 3. PRIORITY-SETTING ACTIVITIES OF SEAR MEMBER STATES ON HEALTH RESEARCH AND DEVELOPMENT
Country
Bangladesh Identification of research priorities in Bangladesh falls under the purview of
the Bangladesh Medical Research Council BMRC, a national organization under the Ministry of Health Family Welfare MOHFW.
In 2011, WHO SEARO requested the Bangladesh to examine the “National
RD priorities for Bangladesh and identify priority demonstration projects based on the local pharmaceutical manufacturing industry’s needs for
improved technology and their capabilities for technology absorption, as per road map suggested by the Consultative Expert Working Group CEWG on
Research and Development
The following priority innovative projects were identified: a.
Phytochemical profiling, standardization and quality control of traditional and herbal drugs to ensure their safety and efficacy;
b. Discovery of the new chemical entities from medicinal plants, microbes
and marine sources. c.
Process Development and Validation to Synthesize Active Pharmaceutical Ingredients APIs: Laboratory Scale to Industrial
Scale through Pilot Scale production of bulk drugs. d.
Production of high value biopharmaceuticalscatalysts by recombinant DNA technology and fermentation technology.
Bhutan Initiated a process for research priority setting in November 2014 where a
workshop was held and a report is yet to be published India
Priority setting in India is done based on the following: o
Global Forum for Health Research GFHR, ACHR framework o
WHO SEARO- Regional Priorities o
The WHO-India Country Cooperation Strategy CCS 2012-2017 o
National Institute of Health- Global Priority Indonesia
The National Research Agenda 2010-2014 covered the development of vaccines, drugs of raw materials, traditional medicines, health and medical
devices, etc. The National Research Agenda 2015-2019 on health sector is going to be
finalised based on burden of disease MoH Decree no.872013 provides road map on drugs raw materials
development Myanmar
National Health Policy of Myanmar has a policy guidance to encourage conduct of medical research activities not only on prevailing health problems
but also giving due attention to health system research. Promotion of Health Research should be done with the objective of
conducting health researches that will contribute to health sector development
